Allspring Global Investments Holdings, LLC Seagen Inc. Transaction History

Allspring Global Investments Holdings, LLC

$62.2 Billion
Q1 2024

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 27, 2023	BUY	$191.51 - $216.16 $19.8 Million - $22.3 Million	103,341 New	103,341 $21.9 Million
Q2 2023 Jul 18, 2023	SELL	$187.64 - $206.25 $1.07 Million - $1.18 Million	-5,725 Reduced 4.29%	127,820 $24.6 Million
Q1 2023 Apr 13, 2023	BUY	$127.59 - $203.08 $68,515 - $109,053	537 Added 0.4%	133,545 $27 Million
Q4 2022 Jan 23, 2023	SELL	$117.37 - $139.17 $6.77 Million - $8.03 Million	-57,718 Reduced 30.26%	133,008 $17.1 Billion
Q3 2022 Oct 26, 2022	SELL	$135.27 - $180.11 $721,530 - $960,706	-5,334 Reduced 2.72%	190,726 $26.1 Million

Q2 2022 Jul 25, 2022	BUY	$108.81 - $179.33 $2.58 Million - $4.26 Million	23,728 Added 13.77%	196,060 $34.7 Million
Q1 2022 May 02, 2022	SELL	$119.61 - $157.85 $302,613 - $399,360	-2,530 Reduced 1.45%	172,332 $24.8 Million
Q4 2021 Jan 28, 2022	BUY	$142.57 - $190.86 $24.9 Million - $33.4 Million	174,862 New	174,862 $27 Million

Others Institutions Holding SGEN

# of Institutions

Shares Held

1.26M

Call Options Held

23K

Put Options Held

55.2K

View Full List

About Seagen Inc.

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

More about SGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.

Account